Irazú Oncology Secures $2.6M Seed Investment to Advance Innovative Cancer Vaccine Platform
Oncology Mouse Models: How to Pick the Right Mouse Model for Your Oncology Drug Development Needs?
Published on :Oncology Mouse Models: How to Pick the Right Mouse Model for Your Oncology Drug Development Needs? Mouse models have long been used in oncology drug development. With improved technology, they [….]
Harnessing the Potential of Antibody Drug Conjugates in Oncology
Published on :Join us for Harnessing the Potential of Antibody Drug Conjugates (ADCs) in Oncology, on October 25 at Johnson & Johnson Innovation – JLABS @ Washington, DC. We’ll host industry thought [….]
With Pandemic in Rearview Mirror, BriaCell Charges Ahead with Cancer Immunotherapy
Published on :With Pandemic in Rearview Mirror, BriaCell Charges Ahead with Cancer Immunotherapy By Mark TerryApril 25, 2023 Many biopharma companies had to place their clinical trials on hold during the first [….]
Precision Oncology Europe 2023
Published on :Hear from and meet with the leading figures in precision oncology to explore how companies are innovating in precision medicine, digital pathology and molecular testing to accelerate timelines and reduce [….]
Immuno US 2023
Published on :Discuss the latest strategies to harness the immune system for the development of innovative therapeutics
Biomarkers US 2023
Published on :Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine
Delfi Diagnostics Showcases Next-Generation Liquid Biopsy Platform at the AACR
Published on :Delfi Diagnostics, a Baltimore-based company developing liquid biopsy tests for early cancer detection, will highlight its next-generation liquid biopsy platform at the American Association for Cancer Research’s (AACR) 2023 annual meeting in April.
Oligonucleotides Chemistry & Therapeutics Europe 2023
Published on :Join oligo leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the oligonucleotides [….]
Immunomic Therapeutics Receives FDA Fast Track Designation for ITI-3000, a pDNA Vaccine, in Development for the Treatment of Merkel Cell Carcinoma
Published on :Immunomic Therapeutics Receives FDA Fast Track Designation for ITI-3000, a pDNA Vaccine, in Development for the Treatment of Merkel Cell Carcinoma November 08, 2022 08:30 AM Eastern Standard Time ROCKVILLE, [….]